TapewireFind a company

person · Reporting owner

KENNEDY KOLLEEN T

Disclosed activity across 3 companies

Tapewire entity
47779
SEC CIK
0001531738

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
ICU MEDICAL INC/DEICUI · Entity 2385DirectorMay 13, 2026May 14, 2026
IPG PHOTONICS CORPIPGP · Entity 1767DirectorMay 12, 2026May 14, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

ICU MEDICAL INC/DE

Report date May 13, 2026 · Filed May 14, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect4,539 Reported balance After 2026-05-13 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2026-05-13 · Exercise / conversion · Acquired 1,254 · Balance 4,539

F1: These securities are Restricted Stock Units.

F2: There is neither a purchase price nor an exercise price for Restricted Stock Units.

Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2026-05-13Direct0 Reported balance After 2026-05-13 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2026-05-13 · Exercise / conversion · Disposed 1,254 · Balance 0

F1: These securities are Restricted Stock Units.

F2: There is neither a purchase price nor an exercise price for Restricted Stock Units.

F3: These awards vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first.

Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2027-05-13Direct1,475 Reported balance After 2026-05-13 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2026-05-13 · Grant · Acquired 1,475 · Balance 1,475

F1: These securities are Restricted Stock Units.

F2: There is neither a purchase price nor an exercise price for Restricted Stock Units.

F3: These awards vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first.

Filing footnotes · ownership attribution and instrument terms

F1: These securities are Restricted Stock Units.

F2: There is neither a purchase price nor an exercise price for Restricted Stock Units.

F3: These awards vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first.

IPG PHOTONICS CORP

Report date May 12, 2026 · Filed May 14, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect11,513 Reported balance After 2026-05-12 transaction · row 1
1 source row

Row 1 · 2026-05-12 · Grant · Acquired 2,436 · Balance 11,513

F1: Grant of restricted stock units vesting in full on the earlier of the first anniversary of the grant date or the next annual stockholders' meeting that occurs at least 50 weeks after the prior year's meeting, subject to the Reporting Person's continued services as a director of the Issuer through the vesting date.

Filing footnotes · ownership attribution and instrument terms

F1: Grant of restricted stock units vesting in full on the earlier of the first anniversary of the grant date or the next annual stockholders' meeting that occurs at least 50 weeks after the prior year's meeting, subject to the Reporting Person's continued services as a director of the Issuer through the vesting date.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

VARIAN MEDICAL SYSTEMS INC

Report date April 15, 2021 · Filed April 16, 2021

Section 16 reporting ended · disclosed 2021-04-16. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect0 Reported balance After 2021-04-15 transaction · row 1
1 source row

Row 1 · 2021-04-15 · Disposition to issuer · Disposed 29,249 · Balance 0

F1: Amount of securities beneficially owned at end of reporting period reflect a reduction of 7 shares as a result of a tax correction for the February 16, 2021 RSU vesting.

F2: Disposed of pursuant to merger agreement (the "Merger Agreement") between issuer and Siemens Healthineers I GmbH and certain other parties in exchange for a cash payment of $177.50 per share of common stock.

Non Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $64.68 · Expires 2025-02-08Direct0 Reported balance After 2021-04-15 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2021-04-15 · Disposition to issuer · Disposed 1,630 · Balance 0

F3: Pursuant to the Merger Agreement, these options, which provided for vesting of one third on 2/8/2019, and the remaining shares in 24 equal installments over the 24 months following, were cancelled in exchange for a cash payment representing the difference between $177.50 and the exercise price of each share of underlying common stock.

Non Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $45.73 · Expires 2026-02-14Direct0 Reported balance After 2021-04-15 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2021-04-15 · Disposition to issuer · Disposed 6,002 · Balance 0

F4: Pursuant to the Merger Agreement, these options, which provided for vesting of one third on 2/14/2020, and the remaining shares in 24 equal installments over the 24 months following, were canceled in exchange for a cash award representing the difference between $177.50 and the exercise price of the option of the underlying common stock.

Non Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $30.59 · Expires 2027-02-13Direct0 Reported balance After 2021-04-15 transaction · row 4 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 4 · 2021-04-15 · Disposition to issuer · Disposed 14,122 · Balance 0

F5: Pursuant to the Merger Agreement, these options, which provided for vesting of one third on 2/13/2021, and the remaining shares in 24 equal installments over the 24 months following, were cancelled in exchange for a cash payment representing the difference between $177.50 and the exercise price of each share of underlying common stock.

Restricted Stock UnitsSEC Table II · derivative / convertible securityDirect0 Reported balance After 2021-04-15 transaction · row 5 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 5 · 2021-04-15 · Disposition to issuer · Disposed 1,063 · Balance 0

F6: Each restricted stock unit represents a contingent right to receive one share of VAR common stock.

F7: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal annual installments beginning February 14, 2020, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock.

Restricted Stock UnitsSEC Table II · derivative / convertible securityDirect0 Reported balance After 2021-04-15 transaction · row 6 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 6 · 2021-04-15 · Disposition to issuer · Disposed 12,103 · Balance 0

F6: Each restricted stock unit represents a contingent right to receive one share of VAR common stock.

F8: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal annual installments beginning November 15, 2021, were cancelled in exchange for a cash award equal to $177.50 per unvested share of underlying common stock that will vest and pay out according to the same schedule.

Restricted Stock UnitsSEC Table II · derivative / convertible securityDirect0 Reported balance After 2021-04-15 transaction · row 7 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 7 · 2021-04-15 · Disposition to issuer · Disposed 1,906 · Balance 0

F6: Each restricted stock unit represents a contingent right to receive one share of VAR common stock.

F9: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal annual installments beginning February 15, 2021, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock.

Performance SharesSEC Table II · derivative / convertible securityDirect0 Reported balance After 2021-04-15 transaction · row 8 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 8 · 2021-04-15 · Disposition to issuer · Disposed 8,859 · Balance 0

F10: Each performance stock unit represents a contingent right to receive one share of VAR common stock.

F11: Pursuant to the Merger Agreement, these performance stock units, which were granted November 21, 2019, were cancelled in exchange for a cash payment of $177.50 per share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level.

Performance SharesSEC Table II · derivative / convertible securityDirect0 Reported balance After 2021-04-15 transaction · row 9 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 9 · 2021-04-15 · Disposition to issuer · Disposed 10,777 · Balance 0

F10: Each performance stock unit represents a contingent right to receive one share of VAR common stock.

F12: Pursuant to the Merger Agreement, these performance stock units, which were granted November 15, 2018, were cancelled in exchange for a cash payment of $177.50 per share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level.

Filing footnotes · ownership attribution and instrument terms

F1: Amount of securities beneficially owned at end of reporting period reflect a reduction of 7 shares as a result of a tax correction for the February 16, 2021 RSU vesting.

F2: Disposed of pursuant to merger agreement (the "Merger Agreement") between issuer and Siemens Healthineers I GmbH and certain other parties in exchange for a cash payment of $177.50 per share of common stock.

F3: Pursuant to the Merger Agreement, these options, which provided for vesting of one third on 2/8/2019, and the remaining shares in 24 equal installments over the 24 months following, were cancelled in exchange for a cash payment representing the difference between $177.50 and the exercise price of each share of underlying common stock.

F4: Pursuant to the Merger Agreement, these options, which provided for vesting of one third on 2/14/2020, and the remaining shares in 24 equal installments over the 24 months following, were canceled in exchange for a cash award representing the difference between $177.50 and the exercise price of the option of the underlying common stock.

F5: Pursuant to the Merger Agreement, these options, which provided for vesting of one third on 2/13/2021, and the remaining shares in 24 equal installments over the 24 months following, were cancelled in exchange for a cash payment representing the difference between $177.50 and the exercise price of each share of underlying common stock.

F6: Each restricted stock unit represents a contingent right to receive one share of VAR common stock.

F7: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal annual installments beginning February 14, 2020, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock.

F8: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal annual installments beginning November 15, 2021, were cancelled in exchange for a cash award equal to $177.50 per unvested share of underlying common stock that will vest and pay out according to the same schedule.

F9: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal annual installments beginning February 15, 2021, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock.

F10: Each performance stock unit represents a contingent right to receive one share of VAR common stock.

F11: Pursuant to the Merger Agreement, these performance stock units, which were granted November 21, 2019, were cancelled in exchange for a cash payment of $177.50 per share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level.

F12: Pursuant to the Merger Agreement, these performance stock units, which were granted November 15, 2018, were cancelled in exchange for a cash payment of $177.50 per share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
September 12, 2017 Filed Sep 13, 2017 11:25 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 Exercise / conversionCommon Stock 1,088 $0.00 $0.00
Disclosure

SEC source: 0001127602-17-027364 · form4.xml · nonDerivative · entry 1

KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,688

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan

Read SEC document
September 12, 2017 Filed Sep 19, 2017 20:36 UTC Amendment VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative 1,088 $0.00 Strike: $67.12 $0.00
Disclosure

SEC source: 0001127602-17-027789 · form4a.xml · derivative · entry 2

KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,495

Underlying: Common Stock · 1,088 shares

Expires 2023-02-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Third Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on 2/12/2017, and the remaining shares in 24 equal installments over the 24 months following the first vesting date.

Read SEC document
September 12, 2017 Filed Sep 19, 2017 20:36 UTC Amendment VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 Exercise / conversionCommon Stock 1,088 $67.12 $73,026.56
Disclosure

SEC source: 0001127602-17-027789 · form4a.xml · nonDerivative · entry 1

KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,688

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The amended Form 4 is being filed to disclose the acquisition price of the Common Stock. The shares were acquired by exercising Non-Qualified Stock Options, and the acquisition price is the exercise price of the Non-Qualified Stock Option. The original Form 4 inadvertently disclosed that the shares were acquired at a price of $0; however, the exercise price of the Non-Qualified Stock Option was properly stated in Table II as $67.12.

Read SEC document
August 31, 2017 Filed Sep 1, 2017 15:48 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative 931 $0.00 Strike: $81.97 $0.00
Disclosure

SEC source: 0001127602-17-026832 · form4.xml · derivative · entry 3

KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,593

Underlying: Common Stock · 931 shares

Expires 2022-02-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan

F2 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Third Amended and Restated 2005 Omnibus Stock Plan, which complies with Rule 16b-3. The option vests as follows: one third on 2/13/2016, and the remaining shares in 24 equal installments over the 24 months following the first vesting date.

Read SEC document
August 31, 2017 Filed Sep 1, 2017 15:48 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 SaleCommon Stock 931 $105.00 $97,755.00
Disclosure

SEC source: 0001127602-17-026832 · form4.xml · nonDerivative · entry 2

KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,600

F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan

Read SEC document
August 31, 2017 Filed Sep 1, 2017 15:48 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 Exercise / conversionCommon Stock 931 $81.97 $76,314.07
Disclosure

SEC source: 0001127602-17-026832 · form4.xml · nonDerivative · entry 1

KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,531

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan

Read SEC document
August 14, 2017 Filed Aug 15, 2017 19:56 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative 1,088 $0.00 Strike: $67.12 $0.00
Disclosure

SEC source: 0001127602-17-025683 · form4.xml · derivative · entry 3

KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,583

Underlying: Common Stock · 1,088 shares

Expires 2023-02-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan

F3 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Third Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on 2/12/2017, and the remaining shares in 24 equal installments over the 24 months following the first vesting date.

Read SEC document
August 14, 2017 Filed Aug 15, 2017 19:56 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 SaleCommon Stock 1,088 $97.91 $106,524.77
Disclosure

SEC source: 0001127602-17-025683 · form4.xml · nonDerivative · entry 2

KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,600

F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan

F2 · price: The 1,088 shares were sold in multiple transactions executed on the same day at prices ranging from $97.60 to $98.23. The detailed breakdown of executed sales will be furnished upon request.

Read SEC document
August 14, 2017 Filed Aug 15, 2017 19:56 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 Exercise / conversionCommon Stock 1,088 $67.12 $73,026.56
Disclosure

SEC source: 0001127602-17-025683 · form4.xml · nonDerivative · entry 1

KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,600

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan

Read SEC document
July 13, 2017 Filed Jul 13, 2017 19:59 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative 933 $0.00 Strike: $81.97 $0.00
Disclosure

SEC source: 0001127602-17-023585 · form4.xml · derivative · entry 6

KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,524

Underlying: Common Stock · 933 shares

Expires 2022-02-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan

F4 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Third Amended and Restated 2005 Omnibus Stock Plan, which complies with Rule 16b-3. The option vests as follows: one third on 2/13/2016, and the remaining shares in 24 equal installments over the 24 months following the first vesting date.

Read SEC document
July 13, 2017 Filed Jul 13, 2017 19:59 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 SaleCommon Stock 933 $105.00 $97,965.00
Disclosure

SEC source: 0001127602-17-023585 · form4.xml · nonDerivative · entry 4

KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,600

F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan

Read SEC document
July 13, 2017 Filed Jul 13, 2017 19:59 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 Exercise / conversionCommon Stock 933 $81.97 $76,478.01
Disclosure

SEC source: 0001127602-17-023585 · form4.xml · nonDerivative · entry 3

KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,533

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan

Read SEC document
July 12, 2017 Filed Jul 13, 2017 19:59 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative 1,088 $0.00 Strike: $67.12 $0.00
Disclosure

SEC source: 0001127602-17-023585 · form4.xml · derivative · entry 5

KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,671

Underlying: Common Stock · 1,088 shares

Expires 2023-02-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan

F3 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Third Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on 2/12/2017, and the remaining shares in 24 equal installments over the 24 months following the first vesting date.

Read SEC document
July 12, 2017 Filed Jul 13, 2017 19:59 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 SaleCommon Stock 1,088 $104.49 $113,689.69
Disclosure

SEC source: 0001127602-17-023585 · form4.xml · nonDerivative · entry 2

KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,600

F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan

F2 · price: The 1,088 shares were sold in multiple transactions executed on the same day at prices ranging from $104.29 to $104.61. The detailed breakdown of executed sales will be furnished upon request.

Read SEC document
July 12, 2017 Filed Jul 13, 2017 19:59 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 Exercise / conversionCommon Stock 1,088 $67.12 $73,026.56
Disclosure

SEC source: 0001127602-17-023585 · form4.xml · nonDerivative · entry 1

KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,688

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan

Read SEC document
June 20, 2017 Filed Jun 21, 2017 16:49 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative 26,092 $0.00 Strike: $81.97 $0.00
Disclosure

SEC source: 0001127602-17-022004 · form4.xml · derivative · entry 3

KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,457

Underlying: Common Stock · 26,092 shares

Expires 2022-02-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The stock options were adjusted pursuant to the Employee Matters Agreement between Varian Medical Systems, Inc. ("Varian") and Varex Imaging Corporation ("Varex") relating to the January 28, 2017 distribution by Varian to its stockholders of all of the outstanding shares of the common stock of Varex. Stock options that were outstanding at the time of the distribution were adjusted by multiplying the number of shares subject thereto by 1.1303 and rounding down to the nearest whole share, and dividing the per share exercise price by 1.1303 and rounding up to the nearest cent.

F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan

F2 · shares: The stock options were adjusted pursuant to the Employee Matters Agreement between Varian Medical Systems, Inc. ("Varian") and Varex Imaging Corporation ("Varex") relating to the January 28, 2017 distribution by Varian to its stockholders of all of the outstanding shares of the common stock of Varex. Stock options that were outstanding at the time of the distribution were adjusted by multiplying the number of shares subject thereto by 1.1303 and rounding down to the nearest whole share, and dividing the per share exercise price by 1.1303 and rounding up to the nearest cent.

F3 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Third Amended and Restated 2005 Omnibus Stock Plan, which complies with Rule 16b-3. The option vests as follows: one third on 2/13/2016, and the remaining shares in 24 equal installments over the 24 months following the first vesting date.

F2 · derivative.underlying_shares: The stock options were adjusted pursuant to the Employee Matters Agreement between Varian Medical Systems, Inc. ("Varian") and Varex Imaging Corporation ("Varex") relating to the January 28, 2017 distribution by Varian to its stockholders of all of the outstanding shares of the common stock of Varex. Stock options that were outstanding at the time of the distribution were adjusted by multiplying the number of shares subject thereto by 1.1303 and rounding down to the nearest whole share, and dividing the per share exercise price by 1.1303 and rounding up to the nearest cent.

Read SEC document
June 20, 2017 Filed Jun 21, 2017 16:49 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 SaleCommon Stock 26,092 $105.00 $2,739,660.00
Disclosure

SEC source: 0001127602-17-022004 · form4.xml · nonDerivative · entry 2

KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,600

F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan

Read SEC document
June 20, 2017 Filed Jun 21, 2017 16:49 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 Exercise / conversionCommon Stock 26,092 $81.97 $2,138,761.24
Disclosure

SEC source: 0001127602-17-022004 · form4.xml · nonDerivative · entry 1

KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,692

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan

F2 · shares: The stock options were adjusted pursuant to the Employee Matters Agreement between Varian Medical Systems, Inc. ("Varian") and Varex Imaging Corporation ("Varex") relating to the January 28, 2017 distribution by Varian to its stockholders of all of the outstanding shares of the common stock of Varex. Stock options that were outstanding at the time of the distribution were adjusted by multiplying the number of shares subject thereto by 1.1303 and rounding down to the nearest whole share, and dividing the per share exercise price by 1.1303 and rounding up to the nearest cent.

F2 · price: The stock options were adjusted pursuant to the Employee Matters Agreement between Varian Medical Systems, Inc. ("Varian") and Varex Imaging Corporation ("Varex") relating to the January 28, 2017 distribution by Varian to its stockholders of all of the outstanding shares of the common stock of Varex. Stock options that were outstanding at the time of the distribution were adjusted by multiplying the number of shares subject thereto by 1.1303 and rounding down to the nearest whole share, and dividing the per share exercise price by 1.1303 and rounding up to the nearest cent.

Read SEC document
June 12, 2017 Filed Jun 13, 2017 19:07 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative 1,087 $0.00 Strike: $67.12 $0.00
Disclosure

SEC source: 0001127602-17-021373 · form4.xml · derivative · entry 4

KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,759

Underlying: Common Stock · 1,087 shares

Expires 2023-02-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan

F3 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Third Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on 2/12/2017, and the remaining shares in 24 equal installments over the 24 months following the first vesting date.

Read SEC document
June 12, 2017 Filed Jun 13, 2017 19:07 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 SaleCommon Stock 100 $101.99 $10,199.00
Disclosure

SEC source: 0001127602-17-021373 · form4.xml · nonDerivative · entry 3

KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,600

F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan

Read SEC document
June 12, 2017 Filed Jun 13, 2017 19:07 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 SaleCommon Stock 987 $101.12 $99,800.70
Disclosure

SEC source: 0001127602-17-021373 · form4.xml · nonDerivative · entry 2

KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,700

F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan

F2 · price: The 987 shares were sold in multiple transactions executed on the same day at prices ranging from $100.52 to $101.46. The detailed breakdown of executed sales will be furnished upon request.

Read SEC document
June 12, 2017 Filed Jun 13, 2017 19:07 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 Exercise / conversionCommon Stock 1,087 $67.12 $72,959.44
Disclosure

SEC source: 0001127602-17-021373 · form4.xml · nonDerivative · entry 1

KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,687

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan

Read SEC document
June 01, 2017 Filed Jun 2, 2017 18:59 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative 34,118 $0.00 Strike: $74.06 $0.00
Disclosure

SEC source: 0001127602-17-020394 · form4.xml · derivative · entry 12

KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 34,118 shares

Expires 2021-02-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The stock options were adjusted pursuant to the Employee Matters Agreement between Varian Medical Systems, Inc. ("Varian") and Varex Imaging Corporation ("Varex") relating to the January 28, 2017 distribution by Varian to its stockholders of all of the outstanding shares of the common stock of Varex. Stock options that were outstanding at the time of the distribution were adjusted by multiplying the number of shares subject thereto by 1.1303 and rounding down to the nearest whole share, and dividing the per share exercise price by 1.1303 and rounding up to the nearest cent.

F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan

F2 · shares: The stock options were adjusted pursuant to the Employee Matters Agreement between Varian Medical Systems, Inc. ("Varian") and Varex Imaging Corporation ("Varex") relating to the January 28, 2017 distribution by Varian to its stockholders of all of the outstanding shares of the common stock of Varex. Stock options that were outstanding at the time of the distribution were adjusted by multiplying the number of shares subject thereto by 1.1303 and rounding down to the nearest whole share, and dividing the per share exercise price by 1.1303 and rounding up to the nearest cent.

F10 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Third Amended and Restated 2005 Omnibus Stock Plan, which complies with Rule 16b-3. The option vests as follows: one third on 02/21/2015, and the remaining shares in 24 equal installments over the 24 months following the first vesting date.

F2 · derivative.underlying_shares: The stock options were adjusted pursuant to the Employee Matters Agreement between Varian Medical Systems, Inc. ("Varian") and Varex Imaging Corporation ("Varex") relating to the January 28, 2017 distribution by Varian to its stockholders of all of the outstanding shares of the common stock of Varex. Stock options that were outstanding at the time of the distribution were adjusted by multiplying the number of shares subject thereto by 1.1303 and rounding down to the nearest whole share, and dividing the per share exercise price by 1.1303 and rounding up to the nearest cent.

Read SEC document
June 01, 2017 Filed Jun 2, 2017 18:59 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative 16,318 $0.00 Strike: $67.12 $0.00
Disclosure

SEC source: 0001127602-17-020394 · form4.xml · derivative · entry 11

KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,846

Underlying: Common Stock · 16,318 shares

Expires 2023-02-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The stock options were adjusted pursuant to the Employee Matters Agreement between Varian Medical Systems, Inc. ("Varian") and Varex Imaging Corporation ("Varex") relating to the January 28, 2017 distribution by Varian to its stockholders of all of the outstanding shares of the common stock of Varex. Stock options that were outstanding at the time of the distribution were adjusted by multiplying the number of shares subject thereto by 1.1303 and rounding down to the nearest whole share, and dividing the per share exercise price by 1.1303 and rounding up to the nearest cent.

F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan

F2 · shares: The stock options were adjusted pursuant to the Employee Matters Agreement between Varian Medical Systems, Inc. ("Varian") and Varex Imaging Corporation ("Varex") relating to the January 28, 2017 distribution by Varian to its stockholders of all of the outstanding shares of the common stock of Varex. Stock options that were outstanding at the time of the distribution were adjusted by multiplying the number of shares subject thereto by 1.1303 and rounding down to the nearest whole share, and dividing the per share exercise price by 1.1303 and rounding up to the nearest cent.

F9 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Third Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on 2/12/2017, and the remaining shares in 24 equal installments over the 24 months following the first vesting date.

F2 · derivative.underlying_shares: The stock options were adjusted pursuant to the Employee Matters Agreement between Varian Medical Systems, Inc. ("Varian") and Varex Imaging Corporation ("Varex") relating to the January 28, 2017 distribution by Varian to its stockholders of all of the outstanding shares of the common stock of Varex. Stock options that were outstanding at the time of the distribution were adjusted by multiplying the number of shares subject thereto by 1.1303 and rounding down to the nearest whole share, and dividing the per share exercise price by 1.1303 and rounding up to the nearest cent.

Read SEC document
June 01, 2017 Filed Jun 2, 2017 18:59 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative 6,137 $0.00 Strike: $60.91 $0.00
Disclosure

SEC source: 0001127602-17-020394 · form4.xml · derivative · entry 10

KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,137 shares

Expires 2019-11-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The stock options were adjusted pursuant to the Employee Matters Agreement between Varian Medical Systems, Inc. ("Varian") and Varex Imaging Corporation ("Varex") relating to the January 28, 2017 distribution by Varian to its stockholders of all of the outstanding shares of the common stock of Varex. Stock options that were outstanding at the time of the distribution were adjusted by multiplying the number of shares subject thereto by 1.1303 and rounding down to the nearest whole share, and dividing the per share exercise price by 1.1303 and rounding up to the nearest cent.

F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan

F2 · shares: The stock options were adjusted pursuant to the Employee Matters Agreement between Varian Medical Systems, Inc. ("Varian") and Varex Imaging Corporation ("Varex") relating to the January 28, 2017 distribution by Varian to its stockholders of all of the outstanding shares of the common stock of Varex. Stock options that were outstanding at the time of the distribution were adjusted by multiplying the number of shares subject thereto by 1.1303 and rounding down to the nearest whole share, and dividing the per share exercise price by 1.1303 and rounding up to the nearest cent.

F8 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Third Amended and Restated 2005 Omnibus Stock Plan, which complies with Rule 16b-3. The option vests as follows: one third on 11/09/2013, and the remaining shares in 24 equal installments over the 24 months following the first vesting date.

F2 · derivative.underlying_shares: The stock options were adjusted pursuant to the Employee Matters Agreement between Varian Medical Systems, Inc. ("Varian") and Varex Imaging Corporation ("Varex") relating to the January 28, 2017 distribution by Varian to its stockholders of all of the outstanding shares of the common stock of Varex. Stock options that were outstanding at the time of the distribution were adjusted by multiplying the number of shares subject thereto by 1.1303 and rounding down to the nearest whole share, and dividing the per share exercise price by 1.1303 and rounding up to the nearest cent.

Read SEC document
June 01, 2017 Filed Jun 2, 2017 18:59 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 SaleCommon Stock 20,111 $100.17 $2,014,567.14
Disclosure

SEC source: 0001127602-17-020394 · form4.xml · nonDerivative · entry 9

KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,600

F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan

F6 · price: The 20,111 shares were sold in multiple transactions executed on the same day at prices ranging from $99.67 to $100.66. The detailed breakdown of executed sales will be furnished upon request.

F7 · balance_after: Amount of securities beneficially owned at end of reporting period reflect 241 shares purchased on April 28, 2017 under the Varian Medical Systems, Inc. Employee Stock Purchase Plan.

Read SEC document
June 01, 2017 Filed Jun 2, 2017 18:59 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 SaleCommon Stock 13,607 $99.18 $1,349,607.57
Disclosure

SEC source: 0001127602-17-020394 · form4.xml · nonDerivative · entry 8

KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,711

F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan

F5 · price: The 13,607 shares were sold in multiple transactions executed on the same day at prices ranging from $98.66 to $99.65. The detailed breakdown of executed sales will be furnished upon request.

Read SEC document
June 01, 2017 Filed Jun 2, 2017 18:59 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 SaleCommon Stock 400 $98.63 $39,452.00
Disclosure

SEC source: 0001127602-17-020394 · form4.xml · nonDerivative · entry 7

KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,318

F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan

Read SEC document
June 01, 2017 Filed Jun 2, 2017 18:59 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 SaleCommon Stock 100 $100.69 $10,069.00
Disclosure

SEC source: 0001127602-17-020394 · form4.xml · nonDerivative · entry 6

KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,718

F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan

Read SEC document
June 01, 2017 Filed Jun 2, 2017 18:59 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 SaleCommon Stock 13,250 $100.17 $1,327,317.43
Disclosure

SEC source: 0001127602-17-020394 · form4.xml · nonDerivative · entry 5

KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,818

F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan

F4 · price: The 13,250 shares were sold in multiple transactions executed on the same day at prices ranging from $99.65 to $100.64. The detailed breakdown of executed sales will be furnished upon request.

Read SEC document
June 01, 2017 Filed Jun 2, 2017 18:59 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 SaleCommon Stock 9,105 $99.16 $902,887.31
Disclosure

SEC source: 0001127602-17-020394 · form4.xml · nonDerivative · entry 4

KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,068

F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan

F3 · price: The 9,105 shares were sold in multiple transactions executed on the same day at prices ranging from $98.63 to $99.61. The detailed breakdown of executed sales will be furnished upon request.

Read SEC document
June 01, 2017 Filed Jun 2, 2017 18:59 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 Exercise / conversionCommon Stock 34,118 $74.06 $2,526,779.08
Disclosure

SEC source: 0001127602-17-020394 · form4.xml · nonDerivative · entry 3

KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,173

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan

F2 · shares: The stock options were adjusted pursuant to the Employee Matters Agreement between Varian Medical Systems, Inc. ("Varian") and Varex Imaging Corporation ("Varex") relating to the January 28, 2017 distribution by Varian to its stockholders of all of the outstanding shares of the common stock of Varex. Stock options that were outstanding at the time of the distribution were adjusted by multiplying the number of shares subject thereto by 1.1303 and rounding down to the nearest whole share, and dividing the per share exercise price by 1.1303 and rounding up to the nearest cent.

F2 · price: The stock options were adjusted pursuant to the Employee Matters Agreement between Varian Medical Systems, Inc. ("Varian") and Varex Imaging Corporation ("Varex") relating to the January 28, 2017 distribution by Varian to its stockholders of all of the outstanding shares of the common stock of Varex. Stock options that were outstanding at the time of the distribution were adjusted by multiplying the number of shares subject thereto by 1.1303 and rounding down to the nearest whole share, and dividing the per share exercise price by 1.1303 and rounding up to the nearest cent.

Read SEC document
June 01, 2017 Filed Jun 2, 2017 18:59 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 Exercise / conversionCommon Stock 16,318 $67.12 $1,095,264.16
Disclosure

SEC source: 0001127602-17-020394 · form4.xml · nonDerivative · entry 2

KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,055

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan

F2 · shares: The stock options were adjusted pursuant to the Employee Matters Agreement between Varian Medical Systems, Inc. ("Varian") and Varex Imaging Corporation ("Varex") relating to the January 28, 2017 distribution by Varian to its stockholders of all of the outstanding shares of the common stock of Varex. Stock options that were outstanding at the time of the distribution were adjusted by multiplying the number of shares subject thereto by 1.1303 and rounding down to the nearest whole share, and dividing the per share exercise price by 1.1303 and rounding up to the nearest cent.

F2 · price: The stock options were adjusted pursuant to the Employee Matters Agreement between Varian Medical Systems, Inc. ("Varian") and Varex Imaging Corporation ("Varex") relating to the January 28, 2017 distribution by Varian to its stockholders of all of the outstanding shares of the common stock of Varex. Stock options that were outstanding at the time of the distribution were adjusted by multiplying the number of shares subject thereto by 1.1303 and rounding down to the nearest whole share, and dividing the per share exercise price by 1.1303 and rounding up to the nearest cent.

Read SEC document
June 01, 2017 Filed Jun 2, 2017 18:59 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 Exercise / conversionCommon Stock 6,137 $60.91 $373,804.67
Disclosure

SEC source: 0001127602-17-020394 · form4.xml · nonDerivative · entry 1

KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,737

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan

F2 · shares: The stock options were adjusted pursuant to the Employee Matters Agreement between Varian Medical Systems, Inc. ("Varian") and Varex Imaging Corporation ("Varex") relating to the January 28, 2017 distribution by Varian to its stockholders of all of the outstanding shares of the common stock of Varex. Stock options that were outstanding at the time of the distribution were adjusted by multiplying the number of shares subject thereto by 1.1303 and rounding down to the nearest whole share, and dividing the per share exercise price by 1.1303 and rounding up to the nearest cent.

F2 · price: The stock options were adjusted pursuant to the Employee Matters Agreement between Varian Medical Systems, Inc. ("Varian") and Varex Imaging Corporation ("Varex") relating to the January 28, 2017 distribution by Varian to its stockholders of all of the outstanding shares of the common stock of Varex. Stock options that were outstanding at the time of the distribution were adjusted by multiplying the number of shares subject thereto by 1.1303 and rounding down to the nearest whole share, and dividing the per share exercise price by 1.1303 and rounding up to the nearest cent.

Read SEC document
February 15, 2017 Filed Feb 16, 2017 20:44 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 Exercise / conversionRestricted Stock Units · Derivative 1,344 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-17-006737 · form4.xml · derivative · entry 7

KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,976

Underlying: Common Stock · 1,344 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock.

F5 · derivative.exercise_date: The restricted stock units vest in three equal installments on February 15, 2017, February 15, 2018, and February 15, 2019. Vested shares will be delivered to the reporting person on vest date.

F5 · derivative.expiration_date: The restricted stock units vest in three equal installments on February 15, 2017, February 15, 2018, and February 15, 2019. Vested shares will be delivered to the reporting person on vest date.

Read SEC document
February 15, 2017 Filed Feb 16, 2017 20:44 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 Exercise / conversionRestricted Stock Units · Derivative 2,237 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-17-006737 · form4.xml · derivative · entry 6

KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,320

Underlying: Common Stock · 2,237 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock.

F4 · derivative.exercise_date: The restricted stock units vest in three equal installments on February 15, 2016, February 15, 2017, and February 15, 2018. Vested shares will be delivered to the reporting person on vest date.

F4 · derivative.expiration_date: The restricted stock units vest in three equal installments on February 15, 2016, February 15, 2017, and February 15, 2018. Vested shares will be delivered to the reporting person on vest date.

Read SEC document
February 15, 2017 Filed Feb 16, 2017 20:44 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 Exercise / conversionRestricted Stock Units · Derivative 2,476 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-17-006737 · form4.xml · derivative · entry 5

KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,557

Underlying: Common Stock · 2,476 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock.

F3 · derivative.exercise_date: The restricted stock units vest in three equal installments on February 15, 2015, February 15, 2016, and February 15, 2017. Vested shares will be delivered to the reporting person on vest date.

F3 · derivative.expiration_date: The restricted stock units vest in three equal installments on February 15, 2015, February 15, 2016, and February 15, 2017. Vested shares will be delivered to the reporting person on vest date.

Read SEC document
February 15, 2017 Filed Feb 16, 2017 20:44 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 Tax withholdingCommon Stock 2,160 $81.12 $175,219.20
Disclosure

SEC source: 0001127602-17-006737 · form4.xml · nonDerivative · entry 4

KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,359

F2 · shares: Represents shares withheld from vested restricted stock units for the payment of federal, state and payroll taxes due on vesting.

Read SEC document
February 15, 2017 Filed Feb 16, 2017 20:44 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 Exercise / conversionCommon Stock 1,344 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-17-006737 · form4.xml · nonDerivative · entry 3

KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,519

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock.

Read SEC document
February 15, 2017 Filed Feb 16, 2017 20:44 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 Exercise / conversionCommon Stock 2,237 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-17-006737 · form4.xml · nonDerivative · entry 2

KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,175

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock.

Read SEC document
February 15, 2017 Filed Feb 16, 2017 20:44 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 Exercise / conversionCommon Stock 2,476 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-17-006737 · form4.xml · nonDerivative · entry 1

KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,938

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock.

Read SEC document
February 10, 2017 Filed Feb 14, 2017 18:27 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 GrantRestricted Stock Units · Derivative 5,050 $0.00 $0.00
Disclosure

SEC source: 0001127602-17-006143 · form4.xml · derivative · entry 2

KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,033

Underlying: Common Stock · 5,050 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock.

F3 · derivative.exercise_date: The restricted stock units vest in three equal installments on February 15, 2018, February 15, 2019, and February 15, 2020. Vested shares will be delivered to the reporting person on vest date.

F3 · derivative.expiration_date: The restricted stock units vest in three equal installments on February 15, 2018, February 15, 2019, and February 15, 2020. Vested shares will be delivered to the reporting person on vest date.

F4 · balance_after: Includes restricted stock units that were adjusted pursuant to the Employee Matters Agreement between Varian Medical Systems, Inc. ("Varian") and Varex Imaging Corporation ("Varex") relating to the January 28, 2017 distribution by Varian to its stockholders of all of the outstanding shares of the common stock of Varex. Restricted stock units that were outstanding at the time of the distribution were adjusted by multiplying the number of shares subject thereto by 1.1303 and rounding to the nearest whole share.

Read SEC document
February 10, 2017 Filed Feb 14, 2017 18:27 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 GrantNon Qualified Stock Option (Right to Buy) · Derivative 25,170 $0.00 Strike: $80.40 $0.00
Disclosure

SEC source: 0001127602-17-006143 · form4.xml · derivative · entry 1

KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,170

Underlying: Common Stock · 25,170 shares

Expires 2024-02-10

F1 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Fourth Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on 2/10/2018, and the remaining shares in 24 equal installments over the 24 months following the first vesting date.

Read SEC document
November 18, 2016 Filed Nov 21, 2016 17:13 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 Tax withholdingCommon Stock 1,063 $88.25 $93,809.75
Disclosure

SEC source: 0001127602-16-067913 · form4.xml · nonDerivative · entry 2

KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,462

F2 · shares: Represents shares withheld from vested PSUs for the payment of federal, state and payroll taxes due on settlement.

F3 · balance_after: Amount of securities beneficially owned at end of reporting period reflect 232 shares purchased on April 29, 2016 and 153 shares purchased on October 28, 2016 under the Varian Medical Systems, Inc. Employee Stock Purchase Plan.

Read SEC document
November 18, 2016 Filed Nov 21, 2016 17:13 UTC VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 GrantCommon Stock 2,831 $0.00 $0.00
Disclosure

SEC source: 0001127602-16-067913 · form4.xml · nonDerivative · entry 1

KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,525

F1 · shares: Represents shares issued upon settlement of performance-based unit award (PSUs) granted November 20, 2013.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.